D
aTyr Pharma, Inc. ATYR
$3.57 $0.0150.42%
Recommendation
Sell
Prev Close
$3.55
Volume
228,147
Avg Vol (90D)
1,058,208
Market Cap
$298.00M
Dividend & Yield
--
52-Week Range
$1.42 - $4.66
P/E (TTM)
--
EPS (TTM)
-$0.9368
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
aTyr Pharma Announces Publication Demonstrating Efzofitimod's Immunomodulatory Activity in ...
3/12/2025 - GuruFocus
aTyr Pharma publishes efzofitimod data in Science Translational Medicine
3/12/2025 - The Fly
aTyr Pharma Announces Publication Demonstrating Efzofitimod's Immunomodulatory Activity in Science Translational Medicine
3/12/2025 - Globe Newswire
aTyr Pharma (ATYR, $3.07) Stochastic Oscillator left the oversold zone on March 11, 2025
3/12/2025 - Tickeron - Stocks
aTyr Pharma announces DSMB recommendation for EFZO-FIT study to continue
3/6/2025 - TipRanks Financial Blog
aTyr Pharma announces DSMB recommendation for EFZO-FIT study to continue
3/6/2025 - The Fly
aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT Study in Pulmonary Sarcoidosis
3/6/2025 - Globe Newswire
Atyr PHARMA (ATYR) Projected to Post Earnings on Thursday
3/6/2025 - MarketBeat
aTyr Pharma (ATYR, $3.03) price may climb as it broke lower Bollinger Band on Mar 04, 2025
3/5/2025 - Tickeron - Stocks
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 ...
3/4/2025 - GuruFocus
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
3/4/2025 - Globe Newswire
aTyr Pharma (ATYR, $3.3) price exceeded its 50-day Moving Average on March 03, 2025
3/4/2025 - Tickeron - Stocks
aTyr Pharma (ATYR, $3.3) entered Downtrend as Momentum indicator drops below 0 level on Mar 03, 2025
3/4/2025 - Tickeron - Stocks
aTyr Pharma (ATYR, $3.3) Stochastic Oscillator left the oversold zone on March 03, 2025
3/4/2025 - Tickeron - Stocks
aTyr Pharma (ATYR, $3.87) Moving Average Convergence Divergence (MACD) Histogram turned negative on February 27, 2025
2/28/2025 - Tickeron - Stocks
aTyr Pharma Loses US$47m Market Value But Insiders See Windfall Of US$370k
2/28/2025 - Simply Wall St
The volume for aTyr Pharma stock increased for one day, resulting in a record-breaking daily growth of 307% of the 65-Day Volume Moving Average
2/26/2025 - Tickeron - Stocks
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
2/24/2025 - GuruFocus
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
2/24/2025 - Globe Newswire
aTyr Pharma (ATYR, $4.43) RSI Indicator left the overbought zone on February 20, 2025
2/21/2025 - Tickeron - Stocks
aTyr Pharma (ATYR, $4.43) Aroon Indicator entered an Uptrend on February 20, 2025.
2/21/2025 - Tickeron - Stocks
Atyr PHARMA INC (NASDAQ:ATYR) Receives $19.25 Average PT from Brokerages
2/21/2025 - MarketBeat
aTyr Pharma (ATYR, $4.25) Aroon Indicator entered an Uptrend on February 19, 2025.
2/20/2025 - Tickeron - Stocks
aTyr Pharma (ATYR, $4.25) price may drop as it broke higher Bollinger Band on Feb 19, 2025
2/20/2025 - Tickeron - Stocks
Atyr PHARMA INC (NASDAQ:ATYR) Receives Consensus Recommendation of "Buy" from Brokerages
2/19/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$235.00K
EBITDA (TTM)
-$67.35M
EBIT (TTM)
-$68.05M
Net Income (TTM)
-$63.82M
Balance Sheet
Total Assets (Q)
$91.62M
Total Debt (Q)
$13.57M
Total Liabilities (Q)
$26.48M
Book Value Per Share (Q)
$0.8617
Cash Flow
Cash from Operations (TTM)
-$67.05M
Cash from Investing (TTM)
$41.14M
Cash from Financing (TTM)
$27.06M
Net Change in Cash (TTM)
$1.15M
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 10 and 14 (est)
Price History
Loading...
Beta
0.84
7-Day Total Return
17.16%
30-Day Total Return
-2.20%
60-Day Total Return
17.55%
90-Day Total Return
13.42%
Year to Date Total Return
-9.21%
1-Year Total Return
117.79%
2-Year Total Return
82.05%
3-Year Total Return
-25.26%
5-Year Total Return
32.46%
52-week Low
Jun 21, 2024 - $1.42
52-week High
Feb 21, 2025 - $4.66
Valuation
Market Cap
$298.00M - Micro Cap
Enterprise Value
$245.39M
Price/Sales (TTM)
1,145.16
Price/Book (Q)
4.12
Dividends and Shares
Shares Outstanding
75.80M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.atyrpharma.com
Phone Number
858 731 8389
Address
10240 Sorrento Valley Road
San Diego, CA 92121
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is... more
NASDAQ 03/13/2025 10:00AM Eastern Quotes delayed
Weiss Ratings